Clinical Trial Update: Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether an inhaled corticosteroid provides additional benefit when used with tiotropium in COPD patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled corticosteroid (inhaled corticosteroid)
• tiotropium (tiotropium)

Snippet

Sponsor: Cantonal Hosptal, Baselland | Conditions: COPD | Phase 4 | Status: COMPLETED | Results posted: 2019-07-23